US Patent

US10588975 — Tigecycline compositions and methods of preparation

Formulation · Assigned to Wyeth LLC · Expires 2026-03-13 · 0y expired

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions.

USPTO Abstract

The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer.

Drugs covered by this patent

Patent Metadata

Patent number
US10588975
Jurisdiction
US
Classification
Formulation
Expires
2026-03-13
Drug substance claim
No
Drug product claim
Yes
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.